These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15817937)

  • 1. TRIPS, patents & HIV/AIDS drugs.
    Satyanarayana K
    Indian J Med Res; 2005 Apr; 121(4):211-4. PubMed ID: 15817937
    [No Abstract]   [Full Text] [Related]  

  • 2. Essential AIDS medications in India.
    Thomas J
    Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
    [No Abstract]   [Full Text] [Related]  

  • 3. Affordable antiretroviral drugs for developing countries: dreams of the magic bullet.
    Razum O; Okoye S
    Trop Med Int Health; 2001 Jun; 6(6):421-2. PubMed ID: 11422954
    [No Abstract]   [Full Text] [Related]  

  • 4. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
    Halliburton M
    Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
    Nderitu T
    E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
    [No Abstract]   [Full Text] [Related]  

  • 7. Affordable drug access for developing countries.
    Highleyman L
    BETA; 2001; 14(2):12-25. PubMed ID: 11785481
    [No Abstract]   [Full Text] [Related]  

  • 8. Cheaper HIV/AIDS drugs coming.
    Eggertson L
    CMAJ; 2004 Jun; 170(13):1905. PubMed ID: 15210633
    [No Abstract]   [Full Text] [Related]  

  • 9. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 10. GSK: please extend patent pool to AIDS drugs.
    Douste-Blazy P; Bermudez J
    Lancet; 2009 Apr; 373(9672):1339. PubMed ID: 19376450
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicines for all, not just the rich.
    Davey S
    Bull World Health Organ; 2001; 79(4):377-8. PubMed ID: 11357220
    [No Abstract]   [Full Text] [Related]  

  • 12. Global patent police block cost-reduction efforts.
    Kasper T
    GMHC Treat Issues; 1999 Mar; 13(3):1-2. PubMed ID: 11366201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving access to essential drugs for people living with HIV/AIDS.
    Balasubramaniam K
    Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
    [No Abstract]   [Full Text] [Related]  

  • 14. Global trade and access to medicines: AIDS treatments in Thailand.
    Wilson D; Cawthorne P; Ford N; Aongsonwang S
    Lancet; 1999 Nov; 354(9193):1893-5. PubMed ID: 10584741
    [No Abstract]   [Full Text] [Related]  

  • 15. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 16. Health, trade, and industry officials set to debate access to essential drugs.
    Kapp C
    Lancet; 2001 Apr; 357(9262):1105. PubMed ID: 11297977
    [No Abstract]   [Full Text] [Related]  

  • 17. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 18. [The patent legislation in India fails the HIV/AIDS work].
    Holen Ø
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
    [No Abstract]   [Full Text] [Related]  

  • 19. World CAB meets with Gilead.
    Huff B
    GMHC Treat Issues; 2006; 20(4-7):6-8. PubMed ID: 17228449
    [No Abstract]   [Full Text] [Related]  

  • 20. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.